News

Sequella, a clinical stage biopharmaceutical company, has started its Phase Ib trial for SQ109 with the dosing of the first cohort of volunteers. The Phase Ib study will

System C Healthcare, a provider of IT products and services to the healthcare sector, has acquired the Bluestar UK Group, a developer of healthcare IT solutions, for a

Gene Network Sciences, a biotechnology company, has received a US patent that covers the company’s core model learning and simulation platform, REFS. Gene Network Sciences (GNS) has deployed

Evoke Pharma, a specialty pharmaceutical company, has initiated a Phase IIb clinical trial to evaluate EVK-001 for the treatment of adults with symptoms of diabetic gastroparesis. The metoclopramide

Clarient, a provider of anatomic pathology and molecular testing services, has launched a new breast cancer test that helps physicians identify the probability of a patient’s cancer recurring

According to Sanofi Pasteur, this new facility, located in Swiftwater, Pennsylvania, will incorporate the latest technology in egg-based vaccine production as part of the company’s commitment to produce

The funds will be used for the development of the company’s vaccines for infectious diseases that include influenza, human papillomavirus (HPV), respiratory syncytial virus (RSV) and dengue. Specifically,

As part of the management transition plan, Archemix also announced that the current president and interim CEO Duncan Higgons has accepted a position with another private biotechnology company

D-Pharm plans to initiate the trial later in 2009 following FDA review of the investigational new drug (IND) application and special protocol assessment (SPA). Recently, D-Pharm also obtained